Cytophage Technologies Ltd.

Cytophage Technologies Ltd. is an award-winning biotechnology company based in Winnipeg, Manitoba, founded in 2019. The company specializes in bacteriophage therapy development, utilizing synthetic biology to produce bacteriophages in the lab. This innovative approach accelerates the development and application of bacteriophages to prevent or treat infections, serving as a complement to antibiotics and addressing the global problem of antibiotic resistance. Bacteriophages, which are viruses that specifically target and destroy bacterial cells, have the potential to revolutionize healthcare as they offer a more targeted and sustainable solution to combating bacterial infections. Cytophage's vision is ambitious, aiming to make their products accessible in every hospital, veterinary practice, and agricultural facility to manage incumbent or emergent bacterial infections or contamination. The company's slogan, "Award-winning biotechnology company specializing in bacteriophage therapy development," emphasizes their recognition and expertise in the field. Although specific details about their last investment and investors are not available, Cytophage Technologies Ltd. presents a promising opportunity for venture capitalists looking to invest in the innovative and rapidly evolving landscape of biotechnology.